China Pharmaceutical Chain Industry Report 2009

According to the chain drug stores ranking in7.7.3 Distribution of Chain Drugstores
China in 2009, top 100 enterprises in China7.8 Guangdong Da Shen Lin
pharmaceutical chain industry achieved the sales7.8.1 Profile
revenue of RMB57.24 billion in 2008, increasing by7.8.2 Revenue
RMB13.33 billion (30.35%) than RMB43.91 billion in7.8.3 Distribution of Chain Drugstores
2007.7.9 Yunnan Hongxiang Yixintang
In 2008, the average profit margin of top 1007.9.1 Profile
enterprises was 3.76%, more 0.76 points than7.9.2 Revenue
that in 20077.9.3 Distribution of Chain Drugstores
This report includes 8 chapters and 65 diagrams,7.10 Beijing Jinxiang Pharmacy
covering all major aspects and key enterprises in7.10.1 Profile
China pharmaceutical chain industry. Chapter 17.10.2 Revenue
introduces the development of China7.10.3 Distribution of Chain Drugstores
pharmaceutical chain industry briefly. Chapter 27.11 Tong Ren Tang
analyzes the macroeconomic environment,7.12 Guizhou 1-Tree
industry environment and policies related with7.13 Medicine Shoppe
China pharmaceutical chain industry. Chapter 3, 4,Selected Charts
5 analyze operation, competition patterns and keySales Revenue of Top 100 Enterprises in China
areas of China pharmaceutical chain industry, suchPharmaceutical Chain Industry in Recent Years
as market scale, profitability, competition patternsComparison between Franchise and Direct
and regional difference. Chapter 6 analyzes theMarketing
development trends of China pharmaceutical chainGDP and Its Growth Rate in China, 2002-2008
industry. Finally, Chapter 7 analyzes thePositive Correlation between GDP and Sales
development, revenue distribution and profitabilityRevenue of China Pharmaceutical Chain Industry
of over 10 key Chinese pharmaceuticalMarket Scale of Pharmaceutical Manufacturing,
enterprises, including LBX Pharmacy, Nepstar,Jan-May 2009
Hubei Tongjitang, Chongqing Tongjunge Pharmacy,Sales Growth Rate of China Pharmaceutical
Sinopharm Group Co., Ltd., Chongqing PeaceIndustry, 1990-Feb 2009
Drugstore.Profit Growth Rate of China Pharmaceutical
1 Overview of China Pharmaceutical ChainIndustry, 1990- Feb 2009
IndustryOverall Framework of Health Care Reform
1.1 Rapid DevelopmentForecast for Sales Revenue and Growth Rate of
1.2 Models of Chain OperationChina Pharmaceutical Chain Industry, 2008-2010
1.1.1 Regular ChainSales Revenue of Top 100 Enterprises in China
1.1.2 FranchisePharmaceutical Chain Industry, 2003-2008
1.1.3 ComparisonTop 10 Enterprises in China Pharmaceutical Chain
1.3 ProblemsIndustry by Sales Revenue, 2008
2 Environment for China Pharmaceutical ChainProfit Margin of Top 100 Enterprises in China
IndustryPharmaceutical Chain Industry, 2008
2.1 Macro-economyTop 10 Enterprises in China Pharmaceutical Chain
2.2 IndustryIndustry by Profit Margin, 2008
2.3 PolicyArea Efficiency of Top 100 Enterprises (by Sales
2.3.1 Challenges Brought by New Medical Reform inRevenue) in China Pharmaceutical Chain Industry,
the Short Term2008
2.3.2 Opportunities Brought by New MedicalTop 10 Enterprises in China Pharmaceutical Chain
Reform in the Long RunIndustry by Area Efficiency, 2008
2.3.3 New Medical Reform is Expected to PromoteSalesperson Efficiency of Top 100 Enterprises (by
"the Separation of Hospitals and MedicineSales Revenue) in China Pharmaceutical Chain
3 Operation of China Pharmaceutical ChainIndustry, 2008
IndustryTop 10 Enterprises in China Pharmaceutical Chain
3.1 Key IndicatorsIndustry by Salesperson Efficiency, 2008
3.1.1 Market ScaleAverage indicators of Top 100 Enterprises (by
3.1.2 ProfitSales Revenue) in China Pharmaceutical Chain
3.1.3 EfficiencyIndustry, 2007-2008
3.1.4 Other IndicatorsDrug Structure of Retail Pharmaceutical Market by
3.2 Consumption StructureSales Revenue, Q1-Q3 2008
3.3 Trend of Drug PricesRetail Prices of Drugs in China, 2003-Aug 2009
3.4 Industry ExpansionTotal Number of Drugstores of Top 100
3.5 Operation FormatsEnterprises (by Sales Revenue) in China
4 Competition in China Pharmaceutical ChainPharmaceutical Chain Industry, 2004-2008
IndustryTop 10 Chinese Pharmaceutical Chain Enterprises
4.1 Market Concentrationby Number of Drugstores, 2008
4.2 Competition PatternOperation Formats of Chinese Pharmaceutical
4.3 Comparison of Major EnterprisesChain Enterprises
4.3.1 Overall ScaleMarket Concentration of China Pharmaceutical
4.3.2 Economic BenefitsChain Industry, 2006-2008
5 Key Areas of China Pharmaceutical ChainPharmaceutical Chain Enterprises That have been
IndustryTop 20 in Successive 5 Years by Sales Revenue
5.1 BeijingTop 10 Enterprises in China Pharmaceutical Chain
5.2 ShanghaiIndustry by Growth Rate, 2008
5.3 GuangdongSales Revenue Ranking in China Pharmaceutical
5.4 JiangsuChain Industry, 2008
5.5 HunanTop 20 Chinese Chain Drugstores by Number of
5.6 LiaoningFranchises, 2008
5.7 OthersSales Revenue Ranking in China Pharmaceutical
6 Development Trends of China PharmaceuticalChain Industry by Single Drugstore, 2008
Chain IndustryProfit Comparison between State-owned and
6.1 Market TrendsPrivate enterprises in China Pharmaceutical Chain
6.2 Consumption StructureIndustry, 2008
6.3 Drug PricesSales Revenue of Major Pharmaceutical Chain
6.4 CompetitionEnterprises in Beijing, 2008
6.5 Operation of PharmaciesSales Revenue of Major Pharmaceutical Chain
6.5.1 Drugstores in Marketing EraEnterprises in Shanghai, 2008
6.5.2 Transformation of Traditional PharmaciesSales Revenue of Major Pharmaceutical Chain
6.5.3 Alliances of Small and Medium PharmaciesEnterprises in Guangdong, 2008
6.5.4 Return of Direct ChainsSales Revenue of Major Pharmaceutical Chain
6.5.5 Capital will become the Primary Means forEnterprises in Jiangsu, 2008
Industry ConsolidationSales Revenue of Major Pharmaceutical Chain
6.6 Key FieldsEnterprises in Hunan, 2008
6.6.1 OTC Drug MarketSales Revenue of Major Pharmaceutical Chain
6.6.2 Medicare DrugsEnterprises in Liaoning, 2008
6.6.3 Cosmeceutical StoresSales Revenue of Major Pharmaceutical Chain
7 Key Enterprises in China Pharmaceutical ChainEnterprises in Hubei, 2008
IndustrySales Revenue of Major Pharmaceutical Chain
7.1 LBX PharmacyEnterprises in Yunan, 2008
7.1.1 ProfileSales Revenue of Major Pharmaceutical Chain
7.1.2 RevenueEnterprises in Chongqing, 2008
7.1.3 Distribution of Chain DrugstoresTerminal Pharmaceutical Market Reforms
7.2 NepstarForecast for Sales Revenue of China Retail
7.2.1 ProfilePharmaceutical Market, 2008-2010
7.2.2 RevenueShares of Drugs in Retail Pharmaceutical Market
7.2.3 Distribution of Chain Drugstoresby Sales Revenue, 2007-2008
7.3 Hubei TongjitangDrug Structure of Retail Pharmaceutical Market by
7.3.1 ProfileSales Revenue, 2007-2008
7.3.2 RevenueTop 10 Best-sold Cold Medicines in Retail
7.3.3 Distribution of Chain DrugstoresPharmaceutical Market, 2008
7.4 Chongqing Tongjunge PharmacyRevenue of LBX Pharmacy, 2003-2008
7.4.1 ProfileGeographical Distribution of LBX Pharmacy's
7.4.2 RevenueDrugstores, 2008
7.4.3 Distribution of Chain DrugstoresRevenue of Nepstar, 2003-2008
7.5 Sinopharm Group Co., Ltd.Number and Expansion Rate of Nepstar's
7.5.1 ProfileDrugstores, 2003-2008
7.5.2 RevenueRevenue of Hubei Tongjitang, 2003-2008
7.5.3 Distribution of Chain DrugstoresExpansion Rate of Hubei Tongjitang's Drugstores,
7.6 Liaoning CDFY2003-2008
7.6.1 ProfileRevenue of Chongqing Tongjunge Pharmacy,
7.6.2 Revenue2003-2008
7.6.3 Distribution of Chain DrugstoresExpansion Rate of Chongqing Tongjunge
7.7 Chongqing Peace DrugstorePharmacy's Drugstores, 2003-2008
7.7.1 ProfileRevenue of Sinopharm Group Co., Ltd., 2003-2008
7.7.2 RevenueExpansion Rate of Sinopharm Group Co.